| Quarterly Financials | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 14 | 27 | 18 | 32 | 25 | 31 | 21 |
| Expenses | 9 | 18 | 13 | 18 | 18 | 18 | 17 |
| EBITDA | 6 | 9 | 5 | 14 | 7 | 12 | 4 |
| Operating Profit % | 39 % | 32 % | 29 % | 43 % | 27 % | 40 % | 13 % |
| Depreciation | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 5 | 8 | 4 | 13 | 5 | 10 | 3 |
| Tax | 1 | 2 | 1 | 3 | 1 | 2 | 1 |
| Net Profit | 3 | 7 | 3 | 9 | 4 | 8 | 2 |
| EPS in ₹ | 0.55 | 1.05 | 0.50 | 1.53 | 0.59 | 1.34 | 0.25 |
Gaudium IVF & Women Health
Gaudium IVF & Women Health
127.80
+6.08
(5.00%)
Market Cap
930.22 Cr
PE Ratio
37.92
Volume
3,54,347.00
Day High - Low
127.80 - 119.98
52W High-Low
163.18 - 69.18
Key Fundamentals
Market Cap
930.22 Cr
EPS
3.92
PE Ratio
37.92
PB Ratio
5.76
Book Value
20.92
EBITDA
37.71
Dividend Yield
0.00 %
Industry
Healthcare Sector
Healthcare Service Provider Return on Equity
41.31
Debt to Equity
0.52
Actual
Company News
View All News
Gaudium IVF & Women Health reported a 42% YoY drop in consolidated net profit to ₹177.6 lakh for Q1FY27, driven by one-time marketing spends and hub setup costs.
Gaudium IVF opens new South Extension hub
Jul 15, 2026
Jul 15, 2026Gaudium IVF and Women Health Ltd commenced operations at a new IVF Centre/Hub in South Extension, New Delhi on July 16, 2026. The facility offers advanced fertility and reproductive healthcare services.
Gaudium IVF rectifies FY26 comparative figuresJun 25, 2026
Jun 25, 2026Gaudium IVF and Women Health Ltd corrected regrouping errors in FY26 consolidated results. The changes affect only FY25 comparative figures; FY26 results remain unchanged.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,934.60 | #1 32,431.20 | 59.31 | #1 2,864.20 | 12.11 | #1 510 | 27.24 | 62.50 | |
1,518.40 | 15,623.84 | 79.77 | 814.20 | 16.36 | 182 | 37.56 | 63.91 | |
582.35 | 12,073.73 | 60.14 | 1,671.40 | 24.15 | 191 | 25.61 | 57.76 | |
604.50 | 9,621.54 | 52.94 | 846.00 | 20.48 | 163 | 33.94 | 54.65 | |
682.95 | 6,852.77 | 81.77 | 1,023.40 | 32.93 | 77 | 35.02 | 48.79 | |
553.65 | 1,795.97 | 18.77 | 772.77 | 4.05 | 106 | -19.51 | 48.96 | |
338.55 | 1,763.19 | 50.37 | 310.41 | 21.30 | 34 | 40.22 | 72.37 | |
1,447.80 | 1,242.60 | 21.95 | 141.92 | 27.17 | 61 | -28.57 | 74.97 | |
532.55 | 1,040.76 | #1 14.49 | 498.18 | #1 237.06 | 69 | #1 45.92 | - | |
301.40 | 958.77 | -36.07 | 1,319.27 | 12.68 | -3 | -92.48 | 48.91 |
Growth Rate
Revenue Growth
46.99 %
Net Income Growth
28.06 %
Cash Flow Change
153.49 %
ROE
-17.21 %
ROCE
-15.64 %
EBITDA Margin (Avg.)
-11.61 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 18 | 37 | 57 | 89 | 193 |
| Fixed Assets | 4 | 18 | 19 | 18 | 29 |
| Current Assets | 14 | 18 | 38 | 54 | 73 |
| Capital Work in Progress | 0 | 0 | 0 | 7 | 0 |
| Investments | 0 | 0 | 0 | 5 | 4 |
| Other Assets | 14 | 18 | 39 | 58 | 0 |
| Total Equity & Liabilities | 18 | 37 | 57 | 89 | 193 |
| Current Liabilities | 6 | 10 | 20 | 38 | 39 |
| Non Current Liabilities | 3 | 4 | 4 | 4 | 2 |
| Total Equity | 9 | 23 | 33 | 46 | 152 |
| Reserve & Surplus | 8 | 22 | 32 | 16 | 116 |
| Share Capital | 1 | 1 | 1 | 31 | 36 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 14 | -3 | -5 |
| Investing Activities | -1 | -16 | -5 | -15 |
| Operating Activities | -1 | 24 | 3 | 9 |
| Financing Activities | 3 | 5 | -1 | 2 |
Share Holding
| % Holding | Jan 2025 | Sept 2025 | Feb 2026 | Mar 2026 | Jun 2026 |
| Promoter | 99.98 % | 99.98 % | 71.29 % | 71.29 % | 71.29 % |
| FIIs | 0.00 % | 0.00 % | 9.24 % | 6.70 % | 3.02 % |
| DIIs | 0.00 % | 0.00 % | 5.11 % | 2.62 % | 2.22 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 13.52 % | 14.67 % | 16.78 % |
| Others | 0.02 % | 0.02 % | 0.84 % | 4.73 % | 6.69 % |
| No of Share Holders | 7 | 7 | 7 | 19,854 | 21,910 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 18 Mar 2026 |  Quarterly Result Announcement | NA | 18 Mar 2026 | 81.09 | 85.19 |
| 28 May 2026 | Quarterly Result Announcement | NA | 28 May 2026 | 116.74 | 116.79 |
| 13 Aug 2026 | Quarterly Result Announcement | NA | 13 Aug 2026 | 132.50 | 123.35 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 19, 2026
Aug 19, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 14, 2026
Aug 14, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2026
Aug 14, 2026Announcement under Regulation 30 (LODR)-Investor PresentationAug 14, 2026
Aug 14, 2026Announcement under Regulation 30 (LODR)-Investor PresentationAug 13, 2026
Aug 13, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 13, 2026
Aug 13, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 13, 2026
Aug 13, 2026Statement Of Deviation & Variation For The Quarter Ended June 30 2026Aug 13, 2026
Aug 13, 2026Announcement under Regulation 30 (LODR)-Change in ManagementAug 13, 2026
Aug 13, 2026Announcement under Regulation 30 (LODR)-Change in ManagementAug 13, 2026
Aug 13, 2026Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026Aug 13, 2026
Aug 13, 2026Board Meeting Outcome for Board Meeting Outcome For Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026Aug 13, 2026
Aug 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2026
Aug 11, 2026Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2026.Aug 07, 2026
Aug 07, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 16, 2026
Jul 16, 2026Intimation Under Regulation 30 And Para B Schedule III - Commencement Of Commercial Operations Of New IVF Centre/Hub At South Extension New DelhiJul 15, 2026
Jul 15, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2026
Jul 11, 2026Closure of Trading WindowJun 26, 2026
Jun 26, 2026Gaudium IVF And Women Health Limited Has Informed The Exchange About Corrigendum To The Financial Results Submitted For The Quarter And Year Ended March 31 2026Jun 25, 2026
Jun 25, 2026Board Meeting Outcome for Approval For Setting Up Of Gaudium Women Hospital At Lucknow Uttar PradeshJun 25, 2026
Jun 25, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 08, 2026
Jun 08, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 29, 2026
May 29, 2026Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026May 28, 2026
May 28, 2026Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026May 28, 2026
May 28, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 23, 2026
May 23, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
May 22, 2026Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Audited Standalone And Consolidated Financial Statements/Results Of The Company For The Quarter And Year Ended March 31 2026.May 22, 2026
May 22, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
May 15, 2026Clarification On Price MovementApr 16, 2026
Apr 16, 2026Clarification sought from Gaudium IVF and Women Health LtdApr 16, 2026
Apr 16, 2026Intimation Regarding Change Of Corporate Identification Number Of The CompanyApr 15, 2026
Apr 15, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Apr 10, 2026Gaudium IVF And Women Health Limited Has Updated The Exchange On The Query Received From BSE Limited Vide Its Email Dated April 07 2026 Seeking Additional Details For Corporate Announcement Dated April 06 2026 Filed Under Regulation 30 Of SEBI (LODR) ReguApr 07, 2026
Apr 07, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 06, 2026
Apr 06, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 01, 2026
Apr 01, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 ( "Listing Regulations")Apr 01, 2026
Apr 01, 2026Closure of Trading WindowMar 28, 2026
Mar 28, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 19, 2026
Mar 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 19, 2026
Mar 19, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 18, 2026
Mar 18, 2026Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026
Mar 18, 2026Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026
Mar 18, 2026Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Mar 12, 2026
Mar 12, 2026Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Mar 02, 2026
Mar 02, 2026Intimation Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Mar 02, 2026
Mar 02, 2026Intimation Under Regulation 6(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 02, 2026
Mar 02, 2026Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations")Mar 02, 2026
Mar 02, 2026Technical Indicators
RSI(14)
Neutral 47.06
ATR(14)
Less Volatile 3.37
STOCH(9,6)
Neutral 51.77
STOCH RSI(14)
Overbought 84.63
MACD(12,26)
Bearish -0.30
ADX(14)
Strong Trend 26.99
UO(9)
Bearish 58.45
ROC(12)
Downtrend And Accelerating -1.27
WillR(14)
Neutral -24.52
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
